In the Company of Mavericks  cover image

Peter Keeling of Diaceutics

In the Company of Mavericks

00:00

Diasutics and the DXRX Platform - What's the Scale?

Diasutics' DXRX platform is based on data from over 70,000 labs in 15 countries that are doing some type of cancer testing. The company believes it can drive the adoption of a new diagnostic in under 10 months. It's not diagnostic technology companies but hospitals and commercial labs sitting within our hospitals who need to be changed.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app